img

Global and United States Formulation CDMO Services Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Formulation CDMO Services Market Report & Forecast 2024-2034

Formulation CDMO services refer to a contract development and manufacturing organization that provides pharmaceutical formulation development and manufacturing services. It provides pharmaceutical companies and biotechnology companies with a full range of formulation solutions from the drug development stage to the commercial production stage.
Market Analysis and InsightsGlobal and United States Formulation CDMO Services Market
This report focuses on global and United States Formulation CDMO Services market, also covers the segmentation data of other regions in regional level and county level.
The global Formulation CDMO Services revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
Formulation CDMO services usually include the following servicesformulation development, technology transfer, preparation of prescriptions, process standards, mass production, quality control and analysis, and registration support. Through the preparation CDMO service, the development and manufacture of preparations can be entrusted to professional institutions, thereby reducing their own R&D and production costs, and can speed up the process of launching products with the help of the experience and facilities of CDMO institutions. At the same time, the preparation CDMO service can also help customers ensure the quality, safety and regulatory compliance of preparation products, and improve the market competitiveness of products.
Global Formulation CDMO Services Scope and Market Size
Formulation CDMO Services market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Formulation CDMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Formulation CDMO Services market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Zhejiang Langhua Pharmaceutical
Viva Biotech
Segment by Type
Small Molecule CDMO
Macro-molecular CDMO

Segment by Application


Clinical Application
Commercial Production
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Formulation CDMO Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Formulation CDMO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Formulation CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulation CDMO Services revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Formulation CDMO Services Product Introduction
1.2 Global Formulation CDMO Services Outlook 2018 VS 2022 VS 2033
1.2.1 Global Formulation CDMO Services Market Size for the Year 2018-2033
1.2.2 United States Formulation CDMO Services Market Size for the Year 2018-2033
1.3 Formulation CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Formulation CDMO Services in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Formulation CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Formulation CDMO Services Market Dynamics
1.4.1 Formulation CDMO Services Industry Trends
1.4.2 Formulation CDMO Services Market Drivers
1.4.3 Formulation CDMO Services Market Challenges
1.4.4 Formulation CDMO Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Formulation CDMO Services by Type
2.1 Formulation CDMO Services Market Segment by Type
2.1.1 Small Molecule CDMO
2.1.2 Macro-molecular CDMO
2.2 Global Formulation CDMO Services Market Size by Type (2018, 2022 & 2033)
2.3 Global Formulation CDMO Services Market Size by Type (2018-2033)
2.4 United States Formulation CDMO Services Market Size by Type (2018, 2022 & 2033)
2.5 United States Formulation CDMO Services Market Size by Type (2018-2033)
3 Formulation CDMO Services by Application
3.1 Formulation CDMO Services Market Segment by Application
3.1.1 Clinical Application
3.1.2 Commercial Production
3.2 Global Formulation CDMO Services Market Size by Application (2018, 2022 & 2033)
3.3 Global Formulation CDMO Services Market Size by Application (2018-2033)
3.4 United States Formulation CDMO Services Market Size by Application (2018, 2022 & 2033)
3.5 United States Formulation CDMO Services Market Size by Application (2018-2033)
4 Global Formulation CDMO Services Competitor Landscape by Company
4.1 Global Formulation CDMO Services Market Size by Company
4.1.1 Global Key Companies of Formulation CDMO Services, Ranked by Revenue (2022)
4.1.2 Global Formulation CDMO Services Revenue by Player (2018-2023)
4.2 Global Formulation CDMO Services Concentration Ratio (CR)
4.2.1 Formulation CDMO Services Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Formulation CDMO Services in 2022
4.2.3 Global Formulation CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Formulation CDMO Services Head office and Area Served
4.4 Global Key Players of Formulation CDMO Services, Product and Application
4.5 Global Key Players of Formulation CDMO Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Formulation CDMO Services Market Size by Company
4.7.1 Key Players of Formulation CDMO Services in United States, Ranked by Revenue (2022)
4.7.2 United States Formulation CDMO Services Revenue by Players (2021, 2022 & 2023)
5 Global Formulation CDMO Services Market Size by Region
5.1 Global Formulation CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Formulation CDMO Services Market Size by Region (2018-2033)
5.2.1 Global Formulation CDMO Services Market Size by Region: 2018-2023
5.2.2 Global Formulation CDMO Services Market Size by Region (2024-2033)
6 Americas
6.1 Americas Formulation CDMO Services Market Size YoY Growth 2018-2033
6.2 Americas Formulation CDMO Services Market Size by Type
6.2.1 Americas Formulation CDMO Services Market Size by Type (2018-2023)
6.2.2 Americas Formulation CDMO Services Market Size by Type (2024-2033)
6.2.3 Americas Formulation CDMO Services Market Share by Type (2018-2033)
6.3 Americas Formulation CDMO Services Market Size by Application
6.3.1 Americas Formulation CDMO Services Market Size by Application (2018-2023)
6.3.2 Americas Formulation CDMO Services Market Size by Application (2024-2033)
6.3.3 Americas Formulation CDMO Services Market Share by Application (2018-2033)
6.4 Americas Formulation CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Formulation CDMO Services Market Size YoY Growth 2018-2033
7.2 EMEA Formulation CDMO Services Market Size by Type
7.2.1 EMEA Formulation CDMO Services Market Size by Type (2018-2023)
7.2.2 EMEA Formulation CDMO Services Market Size by Type (2024-2033)
7.2.3 EMEA Formulation CDMO Services Market Share by Type (2018-2033)
7.3 EMEA Formulation CDMO Services Market Size by Application
7.3.1 EMEA Formulation CDMO Services Market Size by Application (2018-2023)
7.3.2 EMEA Formulation CDMO Services Market Size by Application (2024-2033)
7.3.3 EMEA Formulation CDMO Services Market Share by Application (2018-2033)
7.4 EMEA Formulation CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Formulation CDMO Services Market Size YoY Growth 2018-2033
8.2 China Formulation CDMO Services Market Size by Type
8.2.1 China Formulation CDMO Services Market Size by Type (2018-2023)
8.2.2 China Formulation CDMO Services Market Size by Type (2024-2033)
8.2.3 China Formulation CDMO Services Market Share by Type (2018-2033)
8.3 China Formulation CDMO Services Market Size by Application
8.3.1 China Formulation CDMO Services Market Size by Application (2018-2023)
8.3.2 China Formulation CDMO Services Market Size by Application (2024-2033)
8.3.3 China Formulation CDMO Services Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Formulation CDMO Services Market Size YoY Growth 2018-2033
9.2 APAC Formulation CDMO Services Market Size by Type
9.2.1 APAC Formulation CDMO Services Market Size by Type (2018-2023)
9.2.2 APAC Formulation CDMO Services Market Size by Type (2024-2033)
9.2.3 APAC Formulation CDMO Services Market Share by Type (2018-2033)
9.3 APAC Formulation CDMO Services Market Size by Application
9.3.1 APAC Formulation CDMO Services Market Size by Application (2018-2023)
9.3.2 APAC Formulation CDMO Services Market Size by Application (2024-2033)
9.3.3 APAC Formulation CDMO Services Market Share by Application (2018-2033)
9.4 APAC Formulation CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Medicilon
10.1.1 Medicilon Company Details
10.1.2 Medicilon Business Overview
10.1.3 Medicilon Formulation CDMO Services Introduction
10.1.4 Medicilon Revenue in Formulation CDMO Services Business (2018-2023)
10.1.5 Medicilon Recent Development
10.2 Gliead
10.2.1 Gliead Company Details
10.2.2 Gliead Business Overview
10.2.3 Gliead Formulation CDMO Services Introduction
10.2.4 Gliead Revenue in Formulation CDMO Services Business (2018-2023)
10.2.5 Gliead Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Details
10.3.2 Boehringer Ingelheim Business Overview
10.3.3 Boehringer Ingelheim Formulation CDMO Services Introduction
10.3.4 Boehringer Ingelheim Revenue in Formulation CDMO Services Business (2018-2023)
10.3.5 Boehringer Ingelheim Recent Development
10.4 Vertex
10.4.1 Vertex Company Details
10.4.2 Vertex Business Overview
10.4.3 Vertex Formulation CDMO Services Introduction
10.4.4 Vertex Revenue in Formulation CDMO Services Business (2018-2023)
10.4.5 Vertex Recent Development
10.5 Mirati Therapeutics
10.5.1 Mirati Therapeutics Company Details
10.5.2 Mirati Therapeutics Business Overview
10.5.3 Mirati Therapeutics Formulation CDMO Services Introduction
10.5.4 Mirati Therapeutics Revenue in Formulation CDMO Services Business (2018-2023)
10.5.5 Mirati Therapeutics Recent Development
10.6 AMPAC
10.6.1 AMPAC Company Details
10.6.2 AMPAC Business Overview
10.6.3 AMPAC Formulation CDMO Services Introduction
10.6.4 AMPAC Revenue in Formulation CDMO Services Business (2018-2023)
10.6.5 AMPAC Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Details
10.7.2 Pfizer Business Overview
10.7.3 Pfizer Formulation CDMO Services Introduction
10.7.4 Pfizer Revenue in Formulation CDMO Services Business (2018-2023)
10.7.5 Pfizer Recent Development
10.8 Polypeptide
10.8.1 Polypeptide Company Details
10.8.2 Polypeptide Business Overview
10.8.3 Polypeptide Formulation CDMO Services Introduction
10.8.4 Polypeptide Revenue in Formulation CDMO Services Business (2018-2023)
10.8.5 Polypeptide Recent Development
10.9 Bachem
10.9.1 Bachem Company Details
10.9.2 Bachem Business Overview
10.9.3 Bachem Formulation CDMO Services Introduction
10.9.4 Bachem Revenue in Formulation CDMO Services Business (2018-2023)
10.9.5 Bachem Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Merck Business Overview
10.10.3 Merck Formulation CDMO Services Introduction
10.10.4 Merck Revenue in Formulation CDMO Services Business (2018-2023)
10.10.5 Merck Recent Development
10.11 Asymchem
10.11.1 Asymchem Company Details
10.11.2 Asymchem Business Overview
10.11.3 Asymchem Formulation CDMO Services Introduction
10.11.4 Asymchem Revenue in Formulation CDMO Services Business (2018-2023)
10.11.5 Asymchem Recent Development
10.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
10.12.3 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Introduction
10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023)
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
10.13 Sinopep
10.13.1 Sinopep Company Details
10.13.2 Sinopep Business Overview
10.13.3 Sinopep Formulation CDMO Services Introduction
10.13.4 Sinopep Revenue in Formulation CDMO Services Business (2018-2023)
10.13.5 Sinopep Recent Development
10.14 Frontier Biotechnologies
10.14.1 Frontier Biotechnologies Company Details
10.14.2 Frontier Biotechnologies Business Overview
10.14.3 Frontier Biotechnologies Formulation CDMO Services Introduction
10.14.4 Frontier Biotechnologies Revenue in Formulation CDMO Services Business (2018-2023)
10.14.5 Frontier Biotechnologies Recent Development
10.15 JYMed
10.15.1 JYMed Company Details
10.15.2 JYMed Business Overview
10.15.3 JYMed Formulation CDMO Services Introduction
10.15.4 JYMed Revenue in Formulation CDMO Services Business (2018-2023)
10.15.5 JYMed Recent Development
10.16 Chengdu Shengnuo Biotechnology
10.16.1 Chengdu Shengnuo Biotechnology Company Details
10.16.2 Chengdu Shengnuo Biotechnology Business Overview
10.16.3 Chengdu Shengnuo Biotechnology Formulation CDMO Services Introduction
10.16.4 Chengdu Shengnuo Biotechnology Revenue in Formulation CDMO Services Business (2018-2023)
10.16.5 Chengdu Shengnuo Biotechnology Recent Development
10.17 Shanghai Soho-Yiming Pharmaceuticals
10.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
10.17.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
10.17.3 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Introduction
10.17.4 Shanghai Soho-Yiming Pharmaceuticals Revenue in Formulation CDMO Services Business (2018-2023)
10.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
10.18 Chinese Peptide Company
10.18.1 Chinese Peptide Company Company Details
10.18.2 Chinese Peptide Company Business Overview
10.18.3 Chinese Peptide Company Formulation CDMO Services Introduction
10.18.4 Chinese Peptide Company Revenue in Formulation CDMO Services Business (2018-2023)
10.18.5 Chinese Peptide Company Recent Development
10.19 Ambio Pharmaceuticals
10.19.1 Ambio Pharmaceuticals Company Details
10.19.2 Ambio Pharmaceuticals Business Overview
10.19.3 Ambio Pharmaceuticals Formulation CDMO Services Introduction
10.19.4 Ambio Pharmaceuticals Revenue in Formulation CDMO Services Business (2018-2023)
10.19.5 Ambio Pharmaceuticals Recent Development
10.20 Zhejiang Peptites Biotech
10.20.1 Zhejiang Peptites Biotech Company Details
10.20.2 Zhejiang Peptites Biotech Business Overview
10.20.3 Zhejiang Peptites Biotech Formulation CDMO Services Introduction
10.20.4 Zhejiang Peptites Biotech Revenue in Formulation CDMO Services Business (2018-2023)
10.20.5 Zhejiang Peptites Biotech Recent Development
10.21 STA Pharmaceutical
10.21.1 STA Pharmaceutical Company Details
10.21.2 STA Pharmaceutical Business Overview
10.21.3 STA Pharmaceutical Formulation CDMO Services Introduction
10.21.4 STA Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023)
10.21.5 STA Pharmaceutical Recent Development
10.22 Zhejiang Langhua Pharmaceutical
10.22.1 Zhejiang Langhua Pharmaceutical Company Details
10.22.2 Zhejiang Langhua Pharmaceutical Business Overview
10.22.3 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Introduction
10.22.4 Zhejiang Langhua Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023)
10.22.5 Zhejiang Langhua Pharmaceutical Recent Development
10.23 Viva Biotech
10.23.1 Viva Biotech Company Details
10.23.2 Viva Biotech Business Overview
10.23.3 Viva Biotech Formulation CDMO Services Introduction
10.23.4 Viva Biotech Revenue in Formulation CDMO Services Business (2018-2023)
10.23.5 Viva Biotech Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Formulation CDMO Services Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Formulation CDMO Services Market Trends
Table 3. Formulation CDMO Services Market Drivers
Table 4. Formulation CDMO Services Market Challenges
Table 5. Formulation CDMO Services Market Restraints
Table 6. Global Formulation CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Formulation CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Formulation CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Formulation CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Formulation CDMO Services, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Formulation CDMO Services Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Formulation CDMO Services Revenue Share by Player, 2018-2023
Table 13. Global Formulation CDMO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Formulation CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Formulation CDMO Services as of 2022)
Table 15. Global Key Players of Formulation CDMO Services, Headquarters and Area Served
Table 16. Global Key Players of Formulation CDMO Services, Product and Application
Table 17. Global Key Players of Formulation CDMO Services, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Formulation CDMO Services in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Formulation CDMO Services Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Formulation CDMO Services Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Formulation CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Formulation CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Formulation CDMO Services Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Formulation CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Formulation CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Formulation CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Formulation CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Formulation CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Formulation CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Formulation CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Formulation CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Formulation CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Formulation CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Formulation CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Formulation CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Formulation CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Formulation CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Formulation CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Formulation CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Formulation CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Formulation CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Formulation CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Formulation CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Formulation CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Formulation CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Formulation CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Formulation CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Formulation CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Formulation CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 51. Medicilon Company Details
Table 52. Medicilon Business Overview
Table 53. Medicilon Formulation CDMO Services Product
Table 54. Medicilon Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Medicilon Recent Development
Table 56. Gliead Company Details
Table 57. Gliead Business Overview
Table 58. Gliead Formulation CDMO Services Product
Table 59. Gliead Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Gliead Recent Development
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Formulation CDMO Services Product
Table 64. Boehringer Ingelheim Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Vertex Company Details
Table 67. Vertex Business Overview
Table 68. Vertex Formulation CDMO Services Product
Table 69. Vertex Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Vertex Recent Development
Table 71. Mirati Therapeutics Company Details
Table 72. Mirati Therapeutics Business Overview
Table 73. Mirati Therapeutics Formulation CDMO Services Product
Table 74. Mirati Therapeutics Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Mirati Therapeutics Recent Development
Table 76. AMPAC Company Details
Table 77. AMPAC Business Overview
Table 78. AMPAC Formulation CDMO Services Product
Table 79. AMPAC Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 80. AMPAC Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Formulation CDMO Services Product
Table 84. Pfizer Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Polypeptide Company Details
Table 87. Polypeptide Business Overview
Table 88. Polypeptide Formulation CDMO Services Product
Table 89. Polypeptide Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 90. Polypeptide Recent Development
Table 91. Bachem Company Details
Table 92. Bachem Business Overview
Table 93. Bachem Formulation CDMO Services Product
Table 94. Bachem Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 95. Bachem Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Formulation CDMO Services Product
Table 99. Merck Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Asymchem Company Details
Table 102. Asymchem Business Overview
Table 103. Asymchem Formulation CDMO Services Product
Table 104. Asymchem Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 105. Asymchem Recent Development
Table 106. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 107. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 108. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product
Table 109. Zhejiang Jiuzhou Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 110. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 111. Sinopep Company Details
Table 112. Sinopep Business Overview
Table 113. Sinopep Formulation CDMO Services Product
Table 114. Sinopep Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 115. Sinopep Recent Development
Table 116. Frontier Biotechnologies Company Details
Table 117. Frontier Biotechnologies Business Overview
Table 118. Frontier Biotechnologies Formulation CDMO Services Product
Table 119. Frontier Biotechnologies Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 120. Frontier Biotechnologies Recent Development
Table 121. JYMed Company Details
Table 122. JYMed Business Overview
Table 123. JYMed Formulation CDMO Services Product
Table 124. JYMed Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 125. JYMed Recent Development
Table 126. Chengdu Shengnuo Biotechnology Company Details
Table 127. Chengdu Shengnuo Biotechnology Business Overview
Table 128. Chengdu Shengnuo Biotechnology Formulation CDMO Services Product
Table 129. Chengdu Shengnuo Biotechnology Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 130. Chengdu Shengnuo Biotechnology Recent Development
Table 131. Shanghai Soho-Yiming Pharmaceuticals Company Details
Table 132. Shanghai Soho-Yiming Pharmaceuticals Business Overview
Table 133. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product
Table 134. Shanghai Soho-Yiming Pharmaceuticals Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 136. Chinese Peptide Company Company Details
Table 137. Chinese Peptide Company Business Overview
Table 138. Chinese Peptide Company Formulation CDMO Services Product
Table 139. Chinese Peptide Company Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 140. Chinese Peptide Company Recent Development
Table 141. Ambio Pharmaceuticals Company Details
Table 142. Ambio Pharmaceuticals Business Overview
Table 143. Ambio Pharmaceuticals Formulation CDMO Services Product
Table 144. Ambio Pharmaceuticals Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 145. Ambio Pharmaceuticals Recent Development
Table 146. Zhejiang Peptites Biotech Company Details
Table 147. Zhejiang Peptites Biotech Business Overview
Table 148. Zhejiang Peptites Biotech Formulation CDMO Services Product
Table 149. Zhejiang Peptites Biotech Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 150. Zhejiang Peptites Biotech Recent Development
Table 151. STA Pharmaceutical Company Details
Table 152. STA Pharmaceutical Business Overview
Table 153. STA Pharmaceutical Formulation CDMO Services Product
Table 154. STA Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 155. STA Pharmaceutical Recent Development
Table 156. Zhejiang Langhua Pharmaceutical Company Details
Table 157. Zhejiang Langhua Pharmaceutical Business Overview
Table 158. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product
Table 159. Zhejiang Langhua Pharmaceutical Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 160. Zhejiang Langhua Pharmaceutical Recent Development
Table 161. Viva Biotech Company Details
Table 162. Viva Biotech Business Overview
Table 163. Viva Biotech Formulation CDMO Services Product
Table 164. Viva Biotech Revenue in Formulation CDMO Services Business (2018-2023) & (US$ Million)
Table 165. Viva Biotech Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Formulation CDMO Services Product Picture
Figure 2. Global Formulation CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Formulation CDMO Services Market Size 2018-2033 (US$ Million)
Figure 4. United States Formulation CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Formulation CDMO Services Market Size 2018-2033 (US$ Million)
Figure 6. United States Formulation CDMO Services Market Share in Global 2018-2033
Figure 7. Formulation CDMO Services Report Years Considered
Figure 8. Product Picture of Small Molecule CDMO
Figure 9. Product Picture of Macro-molecular CDMO
Figure 10. Global Formulation CDMO Services Market Share by Type in 2022 & 2033
Figure 11. Global Formulation CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Formulation CDMO Services Market Share by Type (2018-2033)
Figure 13. United States Formulation CDMO Services Market Share by Type in 2022 & 2033
Figure 14. United States Formulation CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Formulation CDMO Services Market Share by Type (2018-2033)
Figure 16. Product Picture of Clinical Application
Figure 17. Product Picture of Commercial Production
Figure 18. Global Formulation CDMO Services Market Share by Application in 2022 & 2033
Figure 19. Global Formulation CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 20. Global Formulation CDMO Services Market Share by Application (2018-2033)
Figure 21. United States Formulation CDMO Services Market Share by Application in 2022 & 2033
Figure 22. United States Formulation CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 23. United States Formulation CDMO Services Market Share by Application (2018-2033)
Figure 24. The Top 5 and 10 Largest Companies of Formulation CDMO Services in the World: Market Share by Formulation CDMO Services Revenue in 2022
Figure 25. Global Formulation CDMO Services Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 26. Global Formulation CDMO Services Market Share by Region (2018-2033)
Figure 27. Americas Formulation CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 28. Americas Formulation CDMO Services Market Share by Type (2018-2033)
Figure 29. Americas Formulation CDMO Services Market Share by Application (2018-2033)
Figure 30. United States Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 31. Canada Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Mexico Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Brazil Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. EMEA Formulation CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 35. EMEA Formulation CDMO Services Market Share by Type (2018-2033)
Figure 36. EMEA Formulation CDMO Services Market Share by Application (2018-2033)
Figure 37. Europe Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 38. Middle East Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Africa Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. China Formulation CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 41. China Formulation CDMO Services Market Share by Type (2018-2033)
Figure 42. China Formulation CDMO Services Market Share by Application (2018-2033)
Figure 43. APAC Formulation CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. APAC Formulation CDMO Services Market Share by Type (2018-2033)
Figure 45. APAC Formulation CDMO Services Market Share by Application (2018-2033)
Figure 46. Japan Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 47. South Korea Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. China Taiwan Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. Southeast Asia Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. India Formulation CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Medicilon Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 52. Gliead Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 54. Vertex Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 55. Mirati Therapeutics Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 56. AMPAC Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 58. Polypeptide Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 59. Bachem Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 60. Merck Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 61. Asymchem Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 62. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 63. Sinopep Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 64. Frontier Biotechnologies Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 65. JYMed Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 66. Chengdu Shengnuo Biotechnology Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 67. Shanghai Soho-Yiming Pharmaceuticals Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 68. Chinese Peptide Company Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 69. Ambio Pharmaceuticals Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 70. Zhejiang Peptites Biotech Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 71. STA Pharmaceutical Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 72. Zhejiang Langhua Pharmaceutical Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 73. Viva Biotech Revenue Growth Rate in Formulation CDMO Services Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries